ULTIVA

Trials studying ULTIVA

• phase3BEATRIX: A Study to Learn About a Group B Streptococcus Vaccine in Healthy Pregnant Women and Their Babiesrecruitingn=6,000
• phase2A Study to Learn About the Safety and Immune Response of a New Pneumococcal Vaccine in Adultscompletedn=1,363
• phase2A Trial of Tegileridine Fumarate Lnjection for Prolonged Mechanical Ventilation Abirritation in the Intensive Care Unit (ICU)recruitingn=120
• phase2Trial To Evaluate The Safety, Tolerability, And Immunogenicity Of A Multivalent Group B Streptococcus Vaccine In Healthy Nonpregnant Women And Pregnant Women And Their Infantscompletedn=1,208
• phase2Safety and Immunogenicity of RNA-based Vaccines Against SARS-CoV-2 Variants in Healthy Participantscompletedn=1,380
• phase3Phase III Clinical Trial of 13-valent Pneumococcal Conjugate Vaccine (Multivalent Conjugate) in Infantsactive not recruitingn=1,800
• phase1A Study to Learn About a Type of Pneumococcal Vaccine With a New Ingredient (PF-07872411) Intended to Enhance the Effects of the Vaccine Which is Given to Adultscompletedn=90
• phase2Trial to Evaluate the Safety, Tolerability, and Immunogenicity of A Multivalent Group B Streptococcus Vaccine When Administered Concomitantly With Tdap in Healthy Nonpregnant Womencompletedn=306